Triglimilife 2mg/500mg/0.2mg Tablet SR
Marketer
Lakshya Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Triglimilife 2mg/500mg/0.2mg Tablet SR
Diabex Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabex Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with well-controlled glucose levels; abrupt cessation can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function) are recommended.
Primary Ingredients of Triglimilife 2mg/500mg/0.2mg Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Triglimilife 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Triglimilife 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Triglimilife 2mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
Common Side effects of Triglimilife 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Triglimilife 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Triglimilife 2mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or fracture it. Administer this medication on an empty stomach.
How Triglimilife 2mg/500mg/0.2mg Tablet SR works:
Each Triglimilife SR tablet (2mg/500mg/0.2mg) combines three antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Triglimilife 2mg/500mg/0.2mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimilife 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Triglimilife tablets (2mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Triglimilife 2mg/500mg/0.2mg SR tablets in individuals with kidney impairment is likely inadvisable and should be forgone. Physician consultation is recommended. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Triglimilife 2mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a low dose; however, its use is contraindicated in those with severe hepatic dysfunction. Consult a physician for guidance.
What if you forget to take Triglimilife 2mg/500mg/0.2mg Tablet SR :
Should you forget to take your Triglimilife 2mg/500mg/0.2mg Tablet SR, administer it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimilife 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently